scholarly journals Response: High Blood Pressure in Acute Stroke and Subsequent Outcome: A Systematic Review

Author(s):  
Mark Willmot ◽  
Jo Leonardi-Bee ◽  
Philip M.W. Bath
2017 ◽  
Vol 12 (3) ◽  
pp. 215-221 ◽  
Author(s):  
Loreana Sanches Silveira ◽  
Daniela Sayuri Inoue ◽  
Jose Messias Rodrigues da Silva ◽  
Suziane Ungari Cayres ◽  
Diego Giulliano Destro Christofaro

2018 ◽  
Vol 45 (6-8) ◽  
pp. 457-462 ◽  
Author(s):  
Wen Jiang ◽  
Chengyang Hu ◽  
Fengli Li ◽  
Xiaoguo Hua ◽  
Xiujun Zhang

BMJ Open ◽  
2019 ◽  
Vol 9 (7) ◽  
pp. e030121 ◽  
Author(s):  
Tom J Moullaali ◽  
Xia Wang ◽  
Lisa J Woodhouse ◽  
Zhe Kang Law ◽  
Candice Delcourt ◽  
...  

IntroductionConflicting results from multiple randomised trials indicate that the methods and effects of blood pressure (BP) reduction after acute intracerebral haemorrhage (ICH) are complex. The Blood pressure in Acute Stroke Collaboration is an international collaboration, which aims to determine the optimal management of BP after acute stroke including ICH.Methods and analysisA systematic review will be undertaken according to the Preferred Reporting Items for Systematic review and Meta-Analysis of Individual Participant Data (IPD) guideline. A search of Cochrane Central Register of Controlled Trials, EMBASE and MEDLINE from inception will be conducted to identify randomised controlled trials of BP management in adults with acute spontaneous (non-traumatic) ICH enrolled within the first 7 days of symptom onset. Authors of studies that meet the inclusion criteria will be invited to share their IPD. The primary outcome will be functional outcome according to the modified Rankin Scale. Safety outcomes will be early neurological deterioration, symptomatic hypotension and serious adverse events. Secondary outcomes will include death and neuroradiological and haemodynamic variables. Meta-analyses of pooled IPD using the intention-to-treat dataset of included trials, including subgroup analyses to assess modification of the effects of BP lowering by time to treatment, treatment strategy and patient’s demographic, clinical and prestroke neuroradiological characteristics.Ethics and disseminationNo new patient data will be collected nor is there any deviation from the original purposes of each study where ethical approvals were granted; therefore, further ethical approval is not required. Results will be reported in international peer-reviewed journals.PROSPERO registration numberCRD42019141136.


2005 ◽  
Vol 130 (46) ◽  
pp. 2663-2663
Author(s):  
D G Nabavi ◽  
E B Ringelstein

2020 ◽  
Vol 18 (1) ◽  
pp. 5-18 ◽  
Author(s):  
Marina Grand ◽  
Daniel Bia ◽  
Alejandro Diaz

Background: People living with HIV (PLWHIV) have a 2-fold higher risk of having a cardiovascular event than HIV-negative individuals. Objectives: The objective of this article is to estimate the pooled proportion of moderate-high cardiovascular risk in PLWHIV obtained through different scores. In addition, this study also aims to establish the prevalence of dyslipidemia, smoking habits, diabetes and high blood pressure in the included studies. Methods: A bibliographic search was conducted in MEDLINE for studies on cardiovascular risk assessment in PLWHVI that took place during the period of inception to July 2018. The eligibility criteria for inclusion were: cross-sectional or longitudinal studies on HIV-positive adults in which the prevalence of moderate-high cardiovascular risk (or data to calculate it) was reported, and included at least one of the following cardiovascular risk scores: Framingham, ASCVD, D:A:D, Progetto Cuore, PROCAM, SCORE, Regicor, and World Health Organization scores. Results: Bibliographic search identified 278 studies. Finally, thirty-nine peer-reviewed publications were identified for a collective total of 13698 subjects. The pooled prevalence of moderate-high cardiovascular risk in PLWHIV obtained with nine different scores through random-effect modeling was 20.41% (95% CI: 16.77-24.31). The most prevalent concomitant cardiovascular risk factor was dyslipidemia (39.5%), smoking (33.0 %), high blood pressure (19.8%) and diabetes (7.24%). Conclusions: Data obtained in this systematic review indicate that more than 1 in every five subjects with HIV have a moderate-high cardiovascular risk. In consequence, the burden of cardiovascular disease in PLWHIV represents a public health problem. There is an urgent need to develop strategies to prevent and detect cardiovascular risk effectively in PLWHIV.


Heart ◽  
2012 ◽  
Vol 98 (Suppl 2) ◽  
pp. E146.4-E147
Author(s):  
Xiaofan Guo ◽  
Liqiang Zheng ◽  
Jun Wang ◽  
Yang Li ◽  
Xingang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document